 |
Loxoribine |
|---|---|
| Trade Name | |
| Orphan Indication | Common variable immunodeficiency |
| USA Market Approval | USA |
| USA Designation Date | 1992-02-24 00:00:00 |
| Sponsor | R. W. Johnson Pharmaceutical Research Institute;Route 202, P.O. Box 300;Raritan, New Jersey, 08869 |
Related Access Program